recombinant hiv-1 tat protein
Vaccineexperimental
Tat or TAT may refer to: — Wikipedia
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2003 (NCT00505401)
Timeline
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTat ↗
Also known as
- recombinant hiv-1 tat protein
- tat
- tat
- tat protein
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01513135 | Phase 2 | Mar 1, 2012 | Istituto Superiore di Sanità, Italian Ministry of Foreign Affairs - General Direction for Cooperation and Development |
| NCT00751595 | Phase 2 | Sep 1, 2008 | Istituto Superiore di Sanità, National AIDS Center, Istituto Superiore di Sanita, Rome, Italy |
| NCT00529698 | Phase 1 | Jan 1, 2004 | Istituto Superiore di Sanità, National AIDS Center, Istituto Superiore di Sanita, Rome, Italy |
| NCT00505401 | Phase 1 | Dec 1, 2003 | Istituto Superiore di Sanità |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Istituto Superiore di Sanità | Academic/Hospital | 4 | 4 | 2 | 2003 |
| National AIDS Center, Istituto Superiore di Sanita, Rome, Italy | Academic/Hospital | 2 | 0 | 2 | 2004 |
| Italian Ministry of Foreign Affairs - General Direction for Cooperation and Development | Government | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1